Continued revenue decline and widening losses keep OSUR under near-term pressure. Monitor Q2 results for revenue stabilization and upcoming FDA decisions (CT/NG self-test, Colli-Pee) for potential catalysts.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 7 $3.13entry
- T+1 · 6mo ago −2.24%α −3.07% · $3.06
- T+5 · 6mo ago −2.88%α −4.38% · $3.04
- T+20 · 6mo ago +26.20%α +23.06% · $3.95
- T+60 · 4mo ago +32.91%α +29.07% · $4.16
Price Chart
How similar events traded
Executive Summary
OraSure reported Q1 2026 revenue of $27.9M, down 7% YoY, and a GAAP EPS loss of $0.32, wider than the prior year's $0.21 loss. Gross margin improved to 42.3%, and core business (ex-COVID) was nearly flat, but operating losses grew to $23.3M. Q2 guidance of $27M-$30M revenue signals continued stabilization but no near-term profitability.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $27.9M (-7% YoY)
- GAAP EPS -$0.32 vs -$0.21 YoY
- Gross margin 42.3% vs 41.1% YoY
- Operating loss $23.3M vs $17.8M YoY
- Cash & equivalents $177M; repurchased $5M in stock
- Q2 2026 revenue guidance $27M-$30M
Financial Impact
Revenue declined 7% YoY to $27.9M; net loss widened 40% to $22.4M
Risk Factors
- Sustained top-line contraction
- Cash burn rate despite $177M cash
- Regulatory/approval delays for pipeline products
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001116463-26-000037 |
| Exhibit: ex992_q1-26investorupdat.htm | 0001116463-26-000037 |
| Document: osur-20260506.htm | 0001116463-26-000037 |
| Document: 0001116463-26-000037-index-headers.html | 0001116463-26-000037 |
| Document: 0001116463-26-000037-index.html | 0001116463-26-000037 |
| Document: 0001116463-26-000037.txt | 0001116463-26-000037 |
| 8-K Data (Synthetic) | 0001116463-26-000037 |
Track record
20 reports on OSUR
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +39.73% at T+60 after the Mar 13, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago 10-Q/A Neutral 2/10 Entry $3.62 to $3.62 Now $3.60 −0.55% · 0.00% +0.36% vs SPY
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $3.33 to $3.56 Now $3.60 +8.11% ▲ +6.91% +5.59% vs SPY
- Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $3.53 to $3.33 Now $3.60 +1.98% ▼ −5.67% −5.30% vs SPY
- Nov 2, 202614d ago Press Release Neutral 2/10 Entry $3.46 to $3.53 Now $3.60 +4.20% ▲ +2.17% +1.87% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $3.94 to $3.46 Now $3.60 −8.63% ▼ −12.31% −11.83% vs SPY
- Sep 17, 20268w ago SC 13D Bullish 6/10 Entry $3.56 to $3.69 Now $3.60 +1.12% ▲ +3.65% +2.10% vs SPY
- Jul 23, 202616w ago Court Ruling Neutral 3/10 Entry $3.97 to $3.96 Now $3.60 −9.32% ▼ −0.25% −0.27% vs SPY
- Jun 12, 202622w ago Institutional Cluster Mixed 4/10 Entry $4.18 to $4.17 Now $3.60 −13.88% ▼ −0.24% −2.00% vs SPY
- Jun 3, 202623w ago 8-K Neutral 3/10 Entry $4.17 to $4.04 Now $3.60 −13.67% ▼ −3.12% −0.52% vs SPY
- May 6, 202627w ago 8-K Bearish 6/10 Viewing Entry $3.13 to $3.06 Now $3.60 −15.02% ▲ +2.24% +3.07% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers